Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Cancer Research

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-08-2940PMID 19383815
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer

  2010cited by this paper
• High-dose 7-hydroxymethotrexate: Acute toxicity and lethality in a rat model

  2009cited by this paper
• Renal dysfunction during and after high-dose methotrexate

  2009cited by this paper
• Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.

  2008cited by this paper
• Species-Dependent Transport and Modulation Properties of Human and Mouse Multidrug Resistance Protein 2 (MRP2/Mrp2, ABCC2/Abcc2)

  2008cited by this paper
• Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate

  2008cited by this paper
• Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides

  2008cited by this paper
• Midazolam Metabolism in Cytochrome P450 3A Knockout Mice Can Be Attributed to Up-Regulated CYP2C Enzymes

  2008cited by this paper
• Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs.

  2008cited by this paper
• Impact of Basolateral Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 on the Hepatobiliary Disposition of Fexofenadine in Perfused Mouse Livers

  2008cited by this paper
• Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis.

  2008cited by this paper
• Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy

  2007cited by this paper
• Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution.

  2007cited by this paper
• Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice

  2007cited by this paper
• Multidrug Resistance Proteins 2 and 3 Provide Alternative Routes for Hepatic Excretion of Morphine-Glucuronides

  2007cited by this paper
• ABCG2: determining its relevance in clinical drug resistance

  2007cited by this paper
• The Effect of Low pH on Breast Cancer Resistance Protein (ABCG2)-Mediated Transport of Methotrexate, 7-Hydroxymethotrexate, Methotrexate Diglutamate, Folic Acid, Mitoxantrone, Topotecan, and Resveratrol in In Vitro Drug Transport Models

  2007cited by this paper
• High‐dose methotrexate in pediatric acute lymphoblastic leukemia: Impact of ABCC2 polymorphisms on plasma concentrations

  2006cited by this paper
• Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2)

  2006cited by this paper
• Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice

  2006cited by this paper
• Differential Involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in Biliary Excretion of 4-Methylumbelliferyl Glucuronide and Sulfate in the Rat

  2006cited by this paper
• Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.

  2006influential reference
• Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.

  2005cited by this paper
• Modulation of Oral Drug Bioavailability: From Preclinical Mechanism to Therapeutic Application

  2005cited by this paper
• Role of Breast Cancer Resistance Protein (Bcrp1/Abcg2) in the Extrusion of Glucuronide and Sulfate Conjugates from Enterocytes to Intestinal Lumen

  2005cited by this paper
• Sex-Dependent Expression and Activity of the ATP-Binding Cassette Transporter Breast Cancer Resistance Protein (BCRP/ABCG2) in Liver

  2005cited by this paper
• Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics.

  2005cited by this paper
• A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination

  2005cited by this paper
• Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice.

  2004cited by this paper
• Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles

  2004cited by this paper
• Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas

  2004cited by this paper
• Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).

  2003cited by this paper
• Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations

  2003cited by this paper
• The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

  2003cited by this paper
• Mammalian ABC transporters in health and disease.

  2002cited by this paper
• Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo

  2002cited by this paper
• The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria

  2002influential reference
• Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.

  2000cited by this paper
• Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance

  2000cited by this paper
• Antifolate Drugs in Cancer Therapy

  1999cited by this paper
• Clinical Pharmacology and Resistance to Dihydrofolate Reductase Inhibitors

  1999cited by this paper
• Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia--a logistic regression analysis.

  1998cited by this paper
• Immuno-localization of H+/peptide cotransporter in rat digestive tract.

  1996cited by this paper
• Urobilinogen-i is a major derivative of bilirubin in bile of homozygous Gunn rats.

  1990cited by this paper
• Stable and sensitive method for the simultaneous determination of N5-methyltetrahydrofolate, leucovorin, methotrexate and 7-hydroxymethotrexate in biological fluids.

  1989cited by this paper
• Reverse-phase h.p.l.c. separation, quantification and preparation of bilirubin and its conjugates from native bile. Quantitative analysis of the intact tetrapyrroles based on h.p.l.c. of their ethyl anthranilate azo derivatives.

  1985cited by this paper
• Some observations on the human pharmacology of methotrexate.

  1977cited by this paper
• High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.

  1977cited by this paper
• Some observations on the human pharmacology of methotrexate.

  1977cited by this paper
• 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.

  1976cited by this paper
• Methotrexate in Liver and Bile after Intravenous Dosage in Man

  1973cited by this paper
• Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

  1966cited by this paper

• Risk factors associated with high-dose methotrexate induced toxicities in primary central nervous system lymphoma

  2025cites this paper
• Evaluation of Genetic Marker Polymorphisms (MTHFRC677T and ABCC2 C) for Predicting Methotrexate Toxicity in Psoriasis Patients in Egypt: A Case‐Control Study

  2025cites this paper
• Risk factors associated with high-dose methotrexate induced toxicities

  2024cites this paper
• Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs.

  2024cites this paper
• Contribution of aldehyde oxidase to methotrexate-induced hepatotoxicity: in vitro and pharmacoepidemiological approaches

  2024cites this paper
• Optimal Administration of Glycyrrhizin Avoids Pharmacokinetic Interactions With High-dose Methotrexate and Exerts a Hepatoprotective Effect

  2023cites this paper
• ABCC1, ABCG2 and FOXP3: Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis

  2023cites this paper
• Blood ACE Phenotyping for Personalized Medicine: Revelation of Patients with Conformationally Altered ACE

  2023cites this paper
• Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance.

  2021cites this paper
• Concomitant Use of High-dose Methotrexate and Glycyrrhizin Affects Pharmacokinetics of Methotrexate, Resulting in Hepatic Toxicity

  2021cites this paper
• Evaluation of possible pharmacokinetic interaction between methotrexate and proton pump inhibitors in rats

  2020cites this paper
• Steady-State Serum-Concentration of Genistein-Aglycone Is Affected by Formulation: BoneProducts Bioequivalence-Study

  2020cites this paper
• Identification and Characterization of Efflux Transporters That Modulate the Subtoxic Disposition of Diclofenac and Its Metabolites

  2019cites this paper
• Intestinal Transporter-Associated Drug Absorption and Toxicity.

  2019cites this paper
• Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity.

  2019cites this paper
• ABCG2/BCRP: variants, transporter interaction profile of substrates and inhibitors

  2019cites this paper
• Leflunomide Increases Hepatic Exposure to Methotrexate and Its Metabolite by Differentially Regulating Multidrug Resistance–Associated Protein Mrp2/3/4 Transporters via Peroxisome Proliferator–Activated Receptor α Activation

  2018influential citation
• Genetic polymorphism of the methotrexate transporter ABCG2, blood pressure and markers of arterial function in patients with rheumatoid arthritis: repeated cross-sectional study

  2018cites this paper
• Simultaneous determination of tilianin and its metabolites in mice using ultra-high-performance liquid chromatography with tandem mass spectrometry and its application to a pharmacokinetic study.

  2018cites this paper
• Advances in understanding disease mechanisms and potential treatments for Crigler–Najjar syndrome

  2018cites this paper
• Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4) in the Active Efflux of Anionic Drugs Across the Blood-Brain Barrier.

  2017cites this paper
• Membrane Transporters for Bilirubin and Its Conjugates: A Systematic Review

  2017cites this paper
• Computer-Aided Recognition of ABC Transporters Substrates and Its Application to the Development of New Drugs for Refractory Epilepsy.

  2017cites this paper
• ABCC2 (1249G > A) polymorphism implicates altered transport activity for sorafenib

  2017cites this paper
• Application of Quantitative Targeted Absolute Proteomics to Profile Protein Expression Changes of Hepatic Transporters and Metabolizing Enzymes During Cholic Acid-Promoted Liver Regeneration.

  2017cites this paper
• Organic anion transporters 1 (OAT1) and OAT3 meditated the protective effect of rhein on methotrexate-induced nephrotoxicity

  2017cites this paper
• Topología molecular aplicada al reconocimiento de sustratos de la Proteína de Resistencia del Cáncer de Mama (BCRP)

  2016influential citation
• Inherited disorders of bilirubin clearance

  2016cites this paper
• Biliary Elimination of Pemetrexed Is Dependent on Mrp2 in Rats: Potential Mechanism of Variable Response in Nonalcoholic Steatohepatitis

  2016cites this paper
• Acute liver failure impairs function and expression of breast cancer‐resistant protein (BCRP) at rat blood–brain barrier partly via ammonia‐ROS‐ERK1/2 activation

  2016cites this paper
• [Role of breast cancer resistance protein in drug disposition].

  2016cites this paper
• New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition

  2015cites this paper
• Multidrug resistance-associated protein 2 (MRP2) and oxaliplatin transport

  2015cites this paper
• The Modulation of Non-steroidal Anti-inflammatory Toxicity as a Function of the Interplay between Uptake and Efflux Transporters

  2015cites this paper
• MDRGene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines

  2015cites this paper
• What do drug transporters really do?

  2014cites this paper
• Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers.

  2014cites this paper
• In vitro and in vivo effects of sublethal cadmium on the expression of MT2 and ABCC2 genes in grass carp (Ctenopharyngodon idellus).

  2014cites this paper
• Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis.

  2014influential citation
• Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics

  2014cites this paper
• Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.

  2014cites this paper
• Bcrp1;Mdr1a/b;Mrp2 Combination Knockout Mice: Altered Disposition of the Dietary Carcinogen PhIP (2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine) and Its Genotoxic Metabolites

  2014influential citation
• Non-viral nanocarriers for siRNA delivery in breast cancer.

  2014cites this paper
• Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences.

  2014cites this paper
• Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics.

  2014cites this paper
• Three decades of low-dose methotrexate in rheumatoid arthritis: Can we predict toxicity?

  2014cites this paper
• Clinical Pharmacology in Pediatrics

  2014cites this paper
• Methotrexate pharmacogenomics and predictors of therapeutic outcome in rheumatoid arthritis

  2014cites this paper
• Découverte de nouveaux marqueurs pharmacogénomiques de la maladie du greffon contre l'hôte en transplantation de cellules souches hématopoïétiques

  2014cites this paper
• The intestinal absorption of folates.

  2014cites this paper
• Pharmacokinetics.

  2014cites this paper
• CD147 promotes MTX resistance by immune cells through up-regulating ABCG2 expression and function.

  2013cites this paper
• Overcoming methotrexate induced liver toxicity: a role of triterpenoids

  2013cites this paper
• Cancer Therapy : Preclinical In fl uence of Human OATP 1 B 1 , OATP 1 B 3 , and OATP 1 A 2 on the Pharmacokinetics of Methotrexate and Paclitaxel in Humanized Transgenic Mice

  2013cites this paper
• Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications

  2013cites this paper
• Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective

  2013cites this paper
• DMD049254 659..667

  2013cites this paper
• Intestinal drug transporters: an overview.

  2013cites this paper
• Brain Efflux Index To Investigate the Influence of Active Efflux on Brain Distribution of Pemetrexed and Methotrexate

  2013cites this paper
• Breast cancer resistance protein (BCRP)/ABCG2

  2013cites this paper
• The role of multidrug resistance proteins in determining fetal susceptibility to drugs of misuse

  2013cites this paper
• A pilot pharmacogenomics study examining the influence of cytotoxic and metabolising genetic polymorphisms on chemotherapy toxicity and outcome in osteosarcoma

  2013cites this paper
• The proton-coupled folate transporter: physiological and pharmacological roles.

  2013cites this paper
• MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines

  2012cites this paper
• Why we need proper PBPK models to examine intestine and liver oral drug absorption.

  2012cites this paper
• Canalicular ABC transporters and liver disease

  2012cites this paper
• Drug transporters in drug efficacy and toxicity.

  2012cites this paper
• Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

  2012cites this paper
• Contribution of tumoral and host solute carriers to clinical drug response.

  2012cites this paper
• Influence of Human OATP1B1, OATP1B3, and OATP1A2 on the Pharmacokinetics of Methotrexate and Paclitaxel in Humanized Transgenic Mice

  2012cites this paper
• The Steady-State Serum Concentration of Genistein Aglycone Is Affected by Formulation: A Bioequivalence Study of Bone Products

  2012cites this paper
• ABCG2 transporter: therapeutic and physiologic implications in veterinary species.

  2012cites this paper
• Membrane transporters as determinants of the pharmacology of platinum anticancer drugs.

  2012cites this paper
• Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymers.

  2012cites this paper
• ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.

  2011cites this paper
• Modulated pharmacokinetics and increased small intestinal toxicity of methotrexate in bilirubin‐treated rats

  2011cites this paper
• Dose-Dependent Disposition of Methotrexate in Abcc2 and Abcc3 Gene Knockout Murine Models

  2011influential citation
• Transporter-mediated drug-drug interactions.

  2011cites this paper
• Expression of Drug Pump Protein MRP2 in Lipopolysaccharide-Treated Rats and its Impact on the Disposition of Acetaminophen

  2011cites this paper
• Cancer Therapy : Preclinical High Impact of Oatp 1 a / 1 b Transporters on In Vivo Disposition of the Hydrophobic Anticancer Drug Paclitaxel

  2011cites this paper
• Ivermectin interacts with human ABCG2.

  2011cites this paper
• Impact of Abcc2 [Multidrug Resistance-Associated Protein (Mrp) 2], Abcc3 (Mrp3), and Abcg2 (Breast Cancer Resistance Protein) on the Oral Pharmacokinetics of Methotrexate and Its Main Metabolite 7-Hydroxymethotrexate

  2011cites this paper
• In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).

  2011cites this paper
• PharmGKB summary: methotrexate pathway.

  2011cites this paper
• UDP-glucuronosyltransferase 2B7 glucuronidation of the active tamoxifen metabolites

  2011cites this paper
• High Impact of Oatp1a/1b Transporters on In Vivo Disposition of the Hydrophobic Anticancer Drug Paclitaxel

  2010cites this paper
• Therapeutic implications of renal anionic drug transporters.

  2010cites this paper
• ABCC2/Abcc2: a multispecific transporter with dominant excretory functions

  2010cites this paper
• 8. Hepatic Toxicity

  2010cites this paper
• Hepatic Clearance of Reactive Glucuronide Metabolites of Diclofenac in the Mouse Is Dependent on Multiple ATP-Binding Cassette Efflux Transporters

  2010cites this paper
• Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs.

  2010influential citation
• ACTIVE EFFLUX TRANSPORT AND CNS DISTRIBUTION OF THE NOVEL ANTIFOLATE PEMETREXED

  2010cites this paper
• Dexamethasone reduces methotrexate biliary elimination and potentiates its hepatotoxicity in rats.

  2010influential citation
• Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

  2010influential citation
• Complex Pharmacokinetic Behavior of Ezetimibe Depends on Abcc2, Abcc3, and Abcg2

  2009cites this paper
• Chapter 1 Compound transporter knockout mice : powerful tools to unravel the pharmacological and physiological functions of ATP binding cassette drug transporters

  2009cites this paper
• Pharmacokinetic assessment of multiple ATP-binding cassette transporters: the power of combination knockout mice.

  2009cites this paper
• Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo

  2009cites this paper
• ATP-binding cassette transporters in primary central nervous system lymphoma : Decreased expression of MDR 1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells

  year unknowncites this paper